Abstract
Since its inception, the concept of glutamate excitotoxicity has provided a foundational framework for understanding the role played by excitatory amino acids in disease states of the brain. At the same time, it has served as a guiding principle in the development and evaluation of new anti-excitotoxic drugs, many of which show promise as neuroprotective therapies in a number of neurological conditions. The discovery that glutamate receptors on the cell surface can engage, through second messengers such as calcium (Ca2+), nitric oxide (NO), and inositol phospholipids, downstream intracellular signaling cascades involved in cell death helped uncover the complexity of the excitotoxic cascade. The identification of numerous intracellular effectors of excitotoxicity has provided a physiological and pharmacological basis for understanding the cellular and molecular mechanisms behind glutamate-mediated nerve cell injury and its role in neuropsychiatric diseases. More recently, knowledge of the molecular biology of glutamate receptors has allowed, for the first time, the identification of differences in the pattern of expression of glutamate receptors in human populations afflicted by neuropsychiatric diseases. This knowledge will be useful in uncovering genes that may confer individual susceptibility to excitotoxic damage and, as a result, predisposition to the development of certain mental and neurological diseases. In this chapter, the role of glutamate receptor overactivation in excitotoxic cell injury as well as potential neuroprotective therapies for limiting glutamate-mediated neurotoxicity in disease states of the central nervous system will be discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AMPA:
-
2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid)
- ATP:
-
Adenosine-5ā²-triphosphate
- BAD:
-
Bcl-2-associated death promoter
- BAX:
-
Bcl-2-associated X protein
- Bcl-2:
-
B-cell lymphoma 2 protein
- Bcl-XL :
-
B-cell lymphoma ā extra large protein
- Ca2+ :
-
Calcium
- DA:
-
Domoic acid
- DCD:
-
Delayed calcium deregulation
- DNA:
-
Deoxyribonucleic acid
- EAAs:
-
Excitatory amino acids
- ER:
-
Endoplasmic reticulum
- GAPDH:
-
Glyceraldehyde-3-phosphate dehydrogenase
- Glu:
-
L-glutamate
- GluRs:
-
Glutamate receptors
- KA:
-
Kainic acid
- MCU:
-
Mitochondrial calcium uniporter
- mNCX:
-
Mitochondrial Na+/Ca2+ transporter
- mPTP:
-
Mitochondrial permeability transition pore
- NCX:
-
Na+/Ca2+ exchanger
- NMDA:
-
N-methyl-d-aspartic acid
- NO:
-
Nitric oxide
- PMCA:
-
Plasma membrane Ca2+ ATPase
- RNS:
-
Reactive nitrogen species
- ROS:
-
Reactive oxygen species
- SIAH1:
-
Seven in absentia homolog E3 ubiquitin-protein ligase
- VDAC:
-
Voltage-dependent anion-selective channel
- ĪĻm:
-
Inner mitochondrial membrane potential
References
Abramov, A. Y., & Duchen, M. R. (2008). Mechanisms underlying the loss of mitochondrial membrane potential in glutamate excitotoxicity. Biochimica et Biophysica Acta, 1777, 953ā964.
Alexander, S. P., Mathie, A., & Peters, J. A. (2011). Guide to Receptors and Channels (GRAC), 5th edition. British Journal of Pharmacology, 164(Suppl 1), S1āS324.
Ankarcrona, M., Dypbukt, J. M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S. A., & Nicotera, P. (1995). Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Neuron, 15, 961ā973.
Arundine, M., & Tymianski, M. (2004). Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cellular and Molecular Life Sciences, 61, 657ā668.
Bano, D., Young, K. W., Guerin, C. J., Lefeuvre, R., Rothwell, N. J., Naldini, L., Rizzuto, R., Carafoli, E., & Nicotera, P. (2005). Cleavage of the plasma membrane Na+/Ca2+ exchanger in excitotoxicity. Cell, 120, 275ā285.
Beal, M. F. (1998). Excitotoxicity and nitric oxide in Parkinsonās disease pathogenesis. Annals of Neurology, 44, S110āS114.
Bensimon, G., Lacomblez, L., & Meininger, V. (1994). A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. The New England Journal of Medicine, 330, 585ā591.
Benveniste, H., Drejer, J., Schousboe, A., & Diemer, N. H. (1984). Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. Journal of Neurochemistry, 43, 1369ā1374.
Bernardi, P. (1999). Mitochondrial transport of cations: Channels, exchangers, and permeability transition. Physiological Reviews, 79, 1127ā1155.
Bernardi, P., & Von Stockum, S. (2012). The permeability transition pore as a Ca2+ release channel: New answers to an old question. Cell Calcium, 52, 22ā27.
Besancon, E., Guo, S., Lok, J., Tymianski, M., & Lo, E. H. (2008). Beyond NMDA and AMPA glutamate receptors: Emerging mechanisms for ionic imbalance and cell death in stroke. Trends in Pharmacological Sciences, 29, 268ā275.
Bliss, T. V., & Collingridge, G. L. (1993). A synaptic model of memory: Long-term potentiation in the hippocampus. Nature, 361, 31ā39.
Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P., & Lipton, S. A. (1995). Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proceedings of the National Academy of Sciences of the United States of America, 92, 7162ā7166.
Boulter, J., Hollmann, M., Oāshea-Greenfield, A., Hartley, M., Deneris, E., Maron, C., & Heinemann, S. (1990). Molecular cloning and functional expression of glutamate receptor subunit genes. Science, 249, 1033ā1037.
Brorson, J. R., Manzolillo, P. A., & Miller, R. J. (1994). Ca2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells. The Journal of Neuroscience, 14, 187ā197.
Brorson, J. R., Marcuccilli, C. J., & Miller, R. J. (1995). Delayed antagonism of calpain reduces excitotoxicity in cultured neurons. Stroke, 26, 1259ā1266.
Brouns, R., & De Deyn, P. P. (2009). The complexity of neurobiological processes in acute ischemic stroke. Clinical Neurology and Neurosurgery, 111, 483ā495.
Brown, G. C. (2010). Nitric oxide and neuronal death. Nitric Oxide, 23, 153ā165.
Buckingham, S. C., Campbell, S. L., Haas, B. R., Montana, V., Robel, S., Ogunrinu, T., & Sontheimer, H. (2011). Glutamate release by primary brain tumors induces epileptic activity. Nature Medicine, 17, 1269ā1274.
Budd, S. L., & Nicholls, D. G. (1996). Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells. Journal of Neurochemistry, 67, 2282ā2291.
Budd, S. L., Tenneti, L., Lishnak, T., & Lipton, S. A. (2000). Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proceedings of the National Academy of Sciences of the United States of America, 97, 6161ā6166.
Bullock, R., Zauner, A., Woodward, J., & Young, H. F. (1995). Massive persistent release of excitatory amino acids following human occlusive stroke. Stroke, 26, 2187ā2189.
Cao, G., Xing, J., Xiao, X., Liou, A. K., Gao, Y., Yin, X. M., Clark, R. S., Graham, S. H., & Chen, J. (2007). Critical role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic neuronal injury. The Journal of Neuroscience, 27, 9278ā9293.
Chen, H. S., & Lipton, S. A. (2006). The chemical biology of clinically tolerated NMDA receptor antagonists. Journal of Neurochemistry, 97, 1611ā1626.
Chen, H. S., Pellegrini, J. W., Aggarwal, S. K., Lei, S. Z., Warach, S., Jensen, F. E., & Lipton, S. A. (1992). Open-channel block of N-methyl-d-aspartate (NMDA) responses by memantine: Therapeutic advantage against NMDA receptor-mediated neurotoxicity. The Journal of Neuroscience, 12, 4427ā4436.
Chinopoulos, C., & Adam-Vizi, V. (2006). Calcium, mitochondria and oxidative stress in neuronal pathology. Novel aspects of an enduring theme. The FEBS Journal, 273, 433ā450.
Cho, D. H., Nakamura, T., & Lipton, S. A. (2010). Mitochondrial dynamics in cell death and neurodegeneration. Cellular and Molecular Life Sciences, 67, 3435ā3447.
Choi, D. W. (1985). Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neuroscience Letters, 58, 293ā297.
Choi, D. W. (1987). Ionic dependence of glutamate neurotoxicity. The Journal of Neuroscience, 7, 369ā379.
Choi, D. W. (1988). Glutamate neurotoxicity and diseases of the nervous system. Neuron, 1, 623ā634.
Choi, D. W. (1990). Ketamine reduces NMDA receptor mediated neurotoxicity in cortical cultures. In E. F. Domino (Ed.), Status of ketamine in anesthesiology (pp. 549ā555). Ann Arbor, MI: NPP Books.
Choi, D. W., Viseskul, V., Amirthanayagam, M., & Monyer, H. (1989). Aspartate neurotoxicity on cultured cortical neurons. Journal of Neuroscience Research, 23, 116ā121.
Cook, D. J., Teves, L., & Tymianski, M. (2012a). Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain. Nature, 483, 213ā217.
Cook, D. J., Teves, L., & Tymianski, M. (2012b). A translational paradigm for the preclinical evaluation of the stroke neuroprotectant Tat-NR2B9c in gyrencephalic nonhuman primates. Science Translational Medicine, 4, 154ra133.
Cooke, S. F., & Bliss, T. V. (2006). Plasticity in the human central nervous system. Brain, 129, 1659ā1673.
Curtis, D. R., Phillis, J. W., & Watkins, J. C. (1959). Chemical excitation of spinal neurones. Nature, 183, 611ā612.
Curtis, D. R., Phillis, J. W., & Watkins, J. C. (1960). The chemical excitation of spinal neurones by certain acidic amino acids. The Journal of Physiology, 150, 656ā682.
Dāorsi, B., Bonner, H., Tuffy, L. P., Dussmann, H., Woods, I., Courtney, M. J., Ward, M. W., & Prehn, J. H. (2012). Calpains are downstream effectors of bax-dependent excitotoxic apoptosis. The Journal of Neuroscience, 32, 1847ā1858.
David, G., Talbot, J., & Barrett, E. F. (2003). Quantitative estimate of mitochondrial [Ca2+] in stimulated motor nerve terminals. Cell Calcium, 33, 197ā206.
Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S., & Snyder, S. H. (1991). Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proceedings of the National Academy of Sciences of the United States of America, 88, 6368ā6371.
Dawson, V. L., Kizushi, V. M., Huang, P. L., Snyder, S. H., & Dawson, T. M. (1996). Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. The Journal of Neuroscience, 16, 2479ā2487.
Doyle, K. P., Simon, R. P., & Stenzel-Poore, M. P. (2008). Mechanisms of ischemic brain damage. Neuropharmacology, 55, 310ā318.
Duchen, M. R. (2000a). Mitochondria and Ca2+ in cell physiology and pathophysiology. Cell Calcium, 28, 339ā348.
Duchen, M. R. (2000b). Mitochondria and calcium: From cell signalling to cell death. The Journal of Physiology, 529(Pt 1), 57ā68.
Duchen, M. R. (2012). Mitochondria, calcium-dependent neuronal death and neurodegenerative disease. Pflugers Archiv: European Journal of Physiology, 464, 111ā121.
Dugan, L. L., Sensi, S. L., Canzoniero, L. M., Handran, S. D., Rothman, S. M., Lin, T. S., Goldberg, M. P., & Choi, D. W. (1995). Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-d-aspartate. The Journal of Neuroscience, 15, 6377ā6388.
Dumuis, A., Sebben, M., Haynes, L., Pin, J. P., & Bockaert, J. (1988). NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature, 336, 68ā70.
Dykens, J. A. (1994). Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated Ca2+ and Na+: Implications for neurodegeneration. Journal of Neurochemistry, 63, 584ā591.
Dykens, J. A., Stern, A., & Trenkner, E. (1987). Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury. Journal of Neurochemistry, 49, 1222ā1228.
Farooqui, A. A., Ong, W. Y., & Horrocks, L. A. (2008). Neurochemical aspects of excitotoxicity. New York, NY: Springer.
Fleischhacker, W. W., Buchgeher, A., & Schubert, H. (1986). Memantine in the treatment of senile dementia of the Alzheimer type. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 10, 87ā93.
Fumagalli, E., Funicello, M., Rauen, T., Gobbi, M., & Mennini, T. (2008). Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. European Journal of Pharmacology, 578, 171ā176.
Garthwaite, J., Charles, S. L., & Chess-Williams, R. (1988). Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature, 336, 385ā388.
Gereau, R. W., & Swanson, G. (2008). The glutamate receptors. Totowa, NJ: Humana Press.
Gillessen, T., Budd, S. L., & Lipton, S. A. (2002). Excitatory amino acid neurotoxicity. Advances in Experimental Medicine and Biology, 513, 3ā40.
Greenamyre, J. T. (1986). The role of glutamate in neurotransmission and in neurologic disease. Archives of Neurology, 43, 1058ā1063.
Gunter, K. K., Zuscik, M. J., & Gunter, T. E. (1991). The Na+(-independent Ca2+ efflux mechanism of liver mitochondria is not a passive Ca2+/2H+ exchanger. The Journal of Biological Chemistry, 266, 21640ā21648.
Hagberg, H., Lehmann, A., Sandberg, M., Nystrom, B., Jacobson, I., & Hamberger, A. (1985). Ischemia-induced shift of inhibitory and excitatory amino acids from intra- to extracellular compartments. Journal of Cerebral Blood Flow and Metabolism, 5, 413ā419.
Hara, M. R., & Snyder, S. H. (2007). Cell signaling and neuronal death. Annual Review of Pharmacology and Toxicology, 47, 117ā141.
Hara, M. R., Agrawal, N., Kim, S. F., Cascio, M. B., Fujimuro, M., Ozeki, Y., Takahashi, M., Cheah, J. H., Tankou, S. K., Hester, L. D., Ferris, C. D., Hayward, S. D., Snyder, S. H., & Sawa, A. (2005). S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nature Cell Biology, 7, 665ā674.
Hayashi, T. (1952). A physiological study of epileptic seizures following cortical stimulation in animals and its application to human clinics. The Japanese Journal of Physiology, 3, 46ā64.
Hayashi, T. (1954). Effects of sodium glutamate on the nervous system. The Keio Journal of Medicine, 3, 183ā192.
Hollmann, M., & Heinemann, S. (1994). Cloned glutamate receptors. Annual Review of Neuroscience, 17, 31ā108.
Hollmann, M., Oāshea-Greenfield, A., Rogers, S. W., & Heinemann, S. (1989). Cloning by functional expression of a member of the glutamate receptor family. Nature, 342, 643ā648.
Hu, N. W., Ondrejcak, T., & Rowan, M. J. (2012). Glutamate receptors in preclinical research on Alzheimerās disease: Update on recent advances. Pharmacology, Biochemistry, and Behavior, 100, 855ā862.
Ichas, F., Jouaville, L. S., & Mazat, J. P. (1997). Mitochondria are excitable organelles capable of generating and conveying electrical and calcium signals. Cell, 89, 1145ā1153.
Jeffery, B., Barlow, T., Moizer, K., Paul, S., & Boyle, C. (2004). Amnesic shellfish poison. Food and Chemical Toxicology, 42, 545ā557.
Jensen, F. E. (2005). Role of glutamate receptors in periventricular leukomalacia. Journal of Child Neurology, 20, 950ā959.
Kaul, M., Garden, G. A., & Lipton, S. A. (2001). Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature, 410, 988ā994.
Keinanen, K., Wisden, W., Sommer, B., Werner, P., Herb, A., Verdoorn, T. A., Sakmann, B., & Seeburg, P. H. (1990). A family of AMPA-selective glutamate receptors. Science, 249, 556ā560.
Kim, M. J., Jo, D. G., Hong, G. S., Kim, B. J., Lai, M., Cho, D. H., Kim, K. W., Bandyopadhyay, A., Hong, Y. M., Kim, D. H., Cho, C., Liu, J. O., Snyder, S. H., & Jung, Y. K. (2002). Calpain-dependent cleavage of cain/cabin1 activates calcineurin to mediate calcium-triggered cell death. Proceedings of the National Academy of Sciences of the United States of America, 99, 9870ā9875.
Kirichok, Y., Krapivinsky, G., & Clapham, D. E. (2004). The mitochondrial calcium uniporter is a highly selective ion channel. Nature, 427, 360ā364.
Koumura, A., Nonaka, Y., Hyakkoku, K., Oka, T., Shimazawa, M., Hozumi, I., Inuzuka, T., & Hara, H. (2008). A novel calpain inhibitor, ((1S)-1((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl) carbamic acid 5-methoxy-3-oxapentyl ester, protects neuronal cells from cerebral ischemia-induced damage in mice. Neuroscience, 157, 309ā318.
Kroemer, G., Galluzzi, L., & Brenner, C. (2007). Mitochondrial membrane permeabilization in cell death. Physiological Reviews, 87, 99ā163.
Kumar, J., & Mayer, M. L. (2012). Functional insights from glutamate receptor ion channel structures. Annual Review of Physiology, 75, 313ā337.
Kupina, N. C., Nath, R., Bernath, E. E., Inoue, J., Mitsuyoshi, A., Yuen, P. W., Wang, K. K., & Hall, E. D. (2001). The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury. Journal of Neurotrauma, 18, 1229ā1240.
Lacomblez, L., Bensimon, G., Leigh, P. N., Guillet, P., & Meininger, V. (1996). Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet, 347, 1425ā1431.
Lafon-Cazal, M., Pietri, S., Culcasi, M., & Bockaert, J. (1993). NMDA-dependent superoxide production and neurotoxicity. Nature, 364, 535ā537.
Lai, M. M., Burnett, P. E., Wolosker, H., Blackshaw, S., & Snyder, S. H. (1998). Cain, a novel physiologic protein inhibitor of calcineurin. The Journal of Biological Chemistry, 273, 18325ā18331.
Landshamer, S., Hoehn, M., Barth, N., Duvezin-Caubet, S., Schwake, G., Tobaben, S., Kazhdan, I., Becattini, B., Zahler, S., Vollmar, A., Pellecchia, M., Reichert, A., Plesnila, N., Wagner, E., & Culmsee, C. (2008). Bid-induced release of AIF from mitochondria causes immediate neuronal cell death. Cell Death and Differentiation, 15, 1553ā1563.
Latremoliere, A., & Woolf, C. J. (2009). Central sensitization: A generator of pain hypersensitivity by central neural plasticity. The Journal of Pain, 10, 895ā926.
Lau, A., & Tymianski, M. (2010). Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Archiv: European Journal of Physiology, 460, 525ā542.
Lazarewicz, J. W., Wroblewski, J. T., Palmer, M. E., & Costa, E. (1988). Activation of N-methyl-d-aspartate-sensitive glutamate receptors stimulates arachidonic acid release in primary cultures of cerebellar granule cells. Neuropharmacology, 27, 765ā769.
Lefebvre, K. A., & Robertson, A. (2010). Domoic acid and human exposure risks: A review. Toxicon, 56, 218ā230.
Lipton, S. A. (2004). Turning down, but not off. Nature, 428, 473.
Lipton, S. A. (2007). Pathologically activated therapeutics for neuroprotection. Nature Reviews Neuroscience, 8, 803ā808.
Lipton, S. A., & Rosenberg, P. A. (1994). Excitatory amino acids as a final common pathway for neurologic disorders. The New England Journal of Medicine, 330, 613ā622.
Lipton, S. A., Choi, Y. B., Pan, Z. H., Lei, S. Z., Chen, H. S., Sucher, N. J., Loscalzo, J., Singel, D. J., & Stamler, J. S. (1993). A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature, 364, 626ā632.
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., & Wang, X. (1996). Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell, 86, 147ā157.
Liu, J., Liu, M. C., & Wang, K. K. (2008). Calpain in the CNS: From synaptic function to neurotoxicity. Science Signaling, 1, re1.
Lodge, D. (2009). The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature. Neuropharmacology, 56, 6ā21.
Lu, Y. M., Yin, H. Z., Chiang, J., & Weiss, J. H. (1996). Ca2+-permeable AMPA/kainate and NMDA channels: High rate of Ca2+ influx underlies potent induction of injury. The Journal of Neuroscience, 16, 5457ā5465.
Lubisch, W., Beckenbach, E., Bopp, S., Hofmann, H. P., Kartal, A., Kastel, C., Lindner, T., Metz-Garrecht, M., Reeb, J., Regner, F., Vierling, M., & Moller, A. (2003). Benzoylalanine-derived ketoamides carrying vinylbenzyl amino residues: Discovery of potent water-soluble calpain inhibitors with oral bioavailability. Journal of Medicinal Chemistry, 46, 2404ā2412.
Lucas, D. R., & Newhouse, J. P. (1957). The toxic effect of sodium l-glutamate on the inner layers of the retina. Archives of Ophthalmology, 58, 193ā201.
Majewska, M. D., & Bell, J. A. (1990). Ascorbic acid protects neurons from injury induced by glutamate and NMDA. Neuroreport, 1, 194ā196.
Martinez-Ruiz, A., Cadenas, S., & Lamas, S. (2011). Nitric oxide signaling: Classical, less classical, and nonclassical mechanisms. Free Radical Biology & Medicine, 51, 17ā29.
Mattson, M. P. (2003). Excitotoxic and excitoprotective mechanisms: Abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Medicine, 3, 65ā94.
Mattson, M. P., Haughey, N. J., & Nath, A. (2005). Cell death in HIV dementia. Cell Death and Differentiation, 12(Suppl. 1), 893ā904.
Mcshane, R., Areosa Sastre, A., & Minakaran, N. (2006). Memantine for dementia. Cochrane Database of Systematic Reviews, 2, CD003154.
Mehta, A., Prabhakar, M., Kumar, P., Deshmukh, R., & Sharma, P. L. (2013). Excitotoxicity: Bridge to various triggers in neurodegenerative disorders. European Journal of Pharmacology, 698, 6ā18.
Meldrum, B. S. (1993). Excitotoxicity and selective neuronal loss in epilepsy. Brain Pathology, 3, 405ā412.
Miller, R. G., Mitchell, J. D., & Moore, D. H. (2012). Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database of Systematic Reviews, 3, CD001447.
Mucke, L., & Selkoe, D. J. (2012). Neurotoxicity of amyloid beta-protein: Synaptic and network dysfunction. Cold Spring Harbor Perspectives in Medicine, 2, a006338.
Nakamura, T., & Lipton, S. A. (2010). Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: Possible pharmacological strategies. Cell Calcium, 47, 190ā197.
Nakamura, T., & Lipton, S. A. (2011). Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases. Cell Death and Differentiation, 18, 1478ā1486.
Nakanishi, S. (1992). Molecular diversity of glutamate receptors and implications for brain function. Science, 258, 597ā603.
Nicholls, J. G., Martin, A. R., Fuchs, P. A., Brown, D. A., Diamond, M. E., & Weisblat, D. (2012). From neuron to brain (5th ed.). Sunderland, MA: Sinauer Associates.
Nicoletti, F., Bockaert, J., Collingridge, G. L., Conn, P. J., Ferraguti, F., Schoepp, D. D., Wroblewski, J. T., & Pin, J. P. (2011). Metabotropic glutamate receptors: From the workbench to the bedside. Neuropharmacology, 60, 1017ā1041.
Nimmrich, V., Reymann, K. G., Strassburger, M., Schoder, U. H., Gross, G., Hahn, A., Schoemaker, H., Wicke, K., & Moller, A. (2010). Inhibition of calpain prevents NMDA-induced cell death and beta-amyloid-induced synaptic dysfunction in hippocampal slice cultures. British Journal of Pharmacology, 159, 1523ā1531.
Niswender, C. M., & Conn, P. J. (2010). Metabotropic glutamate receptors: Physiology, pharmacology, and disease. Annual Review of Pharmacology and Toxicology, 50, 295ā322.
Oācollins, V. E., Macleod, M. R., Donnan, G. A., Horky, L. L., Van Der Worp, B. H., & Howells, D. W. (2006). 1,026 experimental treatments in acute stroke. Annals of Neurology, 59, 467ā477.
Okamoto, S. (1951). Epileptogenic action of glutamate directly applied into the brains of animals and inhibitory effects of protein and tissue emulsions on its action. Journal of the Physiological Society, Japan, 13, 555ā562.
Olney, J. W. (1969). Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science, 164, 719ā721.
Olney, J. W. (1978). Neurotoxicity of excitatory amino acids. In E. G. McGeer, J. W. Olney, & P. L. McGeer (Eds.), Kainic acid as a tool in neurobiology (pp. 95ā121). New York, NY: Raven Press.
Olney, J. W. (2003). Excitotoxicity, apoptosis and neuropsychiatric disorders. Current Opinion in Pharmacology, 3, 101ā109.
Olney, J. W., & Ho, O. L. (1970). Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature, 227, 609ā611.
Olney, J. W., & Sharpe, L. G. (1969). Brain lesions in an infant rhesus monkey treated with monosodium glutamate. Science, 166, 386ā388.
Olney, J. W., Price, M. T., Labruyere, J., Salles, K. S., Frierdich, G., Mueller, M., & Silverman, E. (1987). Anti-parkinsonian agents are phencyclidine agonists and N-methyl-d-aspartate antagonists. European Journal of Pharmacology, 142, 319ā320.
Orrenius, S., Zhivotovsky, B., & Nicotera, P. (2003). Regulation of cell death: The calcium-apoptosis link. Nature Reviews. Molecular Cell Biology, 4, 552ā565.
Ow, Y. P., Green, D. R., Hao, Z., & Mak, T. W. (2008). Cytochrome c: Functions beyond respiration. Nature Reviews. Molecular Cell Biology, 9, 532ā542.
Perez-Pinzon, M. A., Stetler, R. A., & Fiskum, G. (2012). Novel mitochondrial targets for neuroprotection. Journal of Cerebral Blood Flow and Metabolism, 32, 1362ā1376.
Perl, T. M., Bedard, L., Kosatsky, T., Hockin, J. C., Todd, E. C., & Remis, R. S. (1990). An outbreak of toxic encephalopathy caused by eating mussels contaminated with domoic acid. The New England Journal of Medicine, 322, 1775ā1780.
Pivovarova, N. B., Hongpaisan, J., Andrews, S. B., & Friel, D. D. (1999). Depolarization-induced mitochondrial Ca accumulation in sympathetic neurons: Spatial and temporal characteristics. The Journal of Neuroscience, 19, 6372ā6384.
Polster, B. M., Basanez, G., Etxebarria, A., Hardwick, J. M., & Nicholls, D. G. (2005). Calpain I induces cleavage and release of apoptosis-inducing factor from isolated mitochondria. The Journal of Biological Chemistry, 280, 6447ā6454.
Puttfarcken, P. S., Lyons, W. E., & Coyle, J. T. (1992). Dissociation of nitric oxide generation and kainate-mediated neuronal degeneration in primary cultures of rat cerebellar granule cells. Neuropharmacology, 31, 565ā575.
Rabey, J. M., Nissipeanu, P., & Korczyn, A. D. (1992). Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinsonās disease. Journal of Neural Transmission. Parkinsonās Disease and Dementia Section, 4, 277ā282.
Randall, R. D., & Thayer, S. A. (1992). Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons. The Journal of Neuroscience, 12, 1882ā1895.
Raymond, L. A., Andre, V. M., Cepeda, C., Gladding, C. M., Milnerwood, A. J., & Levine, M. S. (2011). Pathophysiology of Huntingtonās disease: Time-dependent alterations in synaptic and receptor function. Neuroscience, 198, 252ā273.
Rego, A. C., Santos, M. S., & Oliveira, C. R. (2000). Glutamate-mediated inhibition of oxidative phosphorylation in cultured retinal cells. Neurochemistry International, 36, 159ā166.
Reisberg, B., Doody, R., Stoffler, A., Schmitt, F., Ferris, S., & Mobius, H. J. (2003). Memantine in moderate-to-severe Alzheimerās disease. The New England Journal of Medicine, 348, 1333ā1341.
Reynolds, I. J., & Hastings, T. G. (1995). Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. The Journal of Neuroscience, 15, 3318ā3327.
Rigoulet, M., Yoboue, E. D., & Devin, A. (2011). Mitochondrial ROS generation and its regulation: Mechanisms involved in H2O2 signaling. Antioxidants & Redox Signaling, 14, 459ā468.
Rizzuto, R., De Stefani, D., Raffaello, A., & Mammucari, C. (2012). Mitochondria as sensors and regulators of calcium signalling. Nature Reviews. Molecular Cell Biology, 13, 566ā578.
Rothman, S. (1984). Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. The Journal of Neuroscience, 4, 1884ā1891.
Rothman, S. M., & Olney, J. W. (1986). Glutamate and the pathophysiology of hypoxic ā ischemic brain damage. Annals of Neurology, 19, 105ā111.
Rothstein, J. D. (1996). Therapeutic horizons for amyotrophic lateral sclerosis. Current Opinion in Neurobiology, 6, 679ā687.
Sabbagh, M. N., Hake, A. M., Ahmed, S., & Farlow, M. R. (2005). The use of memantine in dementia with Lewy bodies. Journal of Alzheimerās Disease, 7, 285ā289.
Sanz-Blasco, S., Valero, R. A., Rodriguez-Crespo, I., Villalobos, C., & Nunez, L. (2008). Mitochondrial Ca2+ overload underlies AĪ² oligomers neurotoxicity providing an unexpected mechanism of neuroprotection by NSAIDs. PLoS One, 3, e2718.
Sattler, R., Xiong, Z., Lu, W. Y., Hafner, M., Macdonald, J. F., & Tymianski, M. (1999). Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science, 284, 1845ā1848.
Savitz, S. I., & Fisher, M. (2007). Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials. Annals of Neurology, 61, 396ā402.
Siman, R., Noszek, J. C., & Kegerise, C. (1989). Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. The Journal of Neuroscience, 9, 1579ā1590.
Simon, R. P., Swan, J. H., Griffiths, T., & Meldrum, B. S. (1984). Blockade of N-methyl-d-aspartate receptors may protect against ischemic damage in the brain. Science, 226, 850ā852.
Skolnick, P., Popik, P., & Trullas, R. (2009). Glutamate-based antidepressants: 20 years on. Trends in Pharmacological Sciences, 30, 563ā569.
Sladeczek, F., Pin, J. P., Recasens, M., Bockaert, J., & Weiss, S. (1985). Glutamate stimulates inositol phosphate formation in striatal neurones. Nature, 317, 717ā719.
Sugiyama, H., Ito, I., & Hirono, C. (1987). A new type of glutamate receptor linked to inositol phospholipid metabolism. Nature, 325, 531ā533.
Surmeier, D. J., Guzman, J. N., Sanchez-Padilla, J., & Goldberg, J. A. (2011). The origins of oxidant stress in Parkinsonās disease and therapeutic strategies. Antioxidants & Redox Signaling, 14, 1289ā1301.
Susin, S. A., Zamzami, N., Castedo, M., Hirsch, T., Marchetti, P., Macho, A., Daugas, E., Geuskens, M., & Kroemer, G. (1996). Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. The Journal of Experimental Medicine, 184, 1331ā1341.
Sutherland, B. A., Minnerup, J., Balami, J. S., Arba, F., Buchan, A. M., & Kleinschnitz, C. (2012). Neuroprotection for ischaemic stroke: Translation from the bench to the bedside. International Journal of Stroke, 7, 407ā418.
Syntichaki, P., & Tavernarakis, N. (2003). The biochemistry of neuronal necrosis: Rogue biology? Nature Reviews Neuroscience, 4, 672ā684.
Takano, T., Lin, J. H., Arcuino, G., Gao, Q., Yang, J., & Nedergaard, M. (2001). Glutamate release promotes growth of malignant gliomas. Nature Medicine, 7, 1010ā1015.
Teitelbaum, J. S., Zatorre, R. J., Carpenter, S., Gendron, D., Evans, A. C., Gjedde, A., & Cashman, N. R. (1990). Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. The New England Journal of Medicine, 322, 1781ā1787.
Tenneti, L., & Lipton, S. A. (2000). Involvement of activated caspase-3-like proteases in N-methyl-d-aspartate-induced apoptosis in cerebrocortical neurons. Journal of Neurochemistry, 74, 134ā142.
Tenneti, L., Dāemilia, D. M., Troy, C. M., & Lipton, S. A. (1998). Role of caspases in N-methyl-d-aspartate-induced apoptosis in cerebrocortical neurons. Journal of Neurochemistry, 71, 946ā959.
Thayer, S. A., & Wang, G. J. (1995). Glutamate-induced calcium loads: Effects on energy metabolism and neuronal viability. Clinical and Experimental Pharmacology & Physiology, 22, 303ā304.
Trapp, B. D., & Stys, P. K. (2009). Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurology, 8, 280ā291.
Traynelis, S. F., Wollmuth, L. P., Mcbain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010). Glutamate receptor ion channels: Structure, regulation, and function. Pharmacological Reviews, 62, 405ā496.
Troy, C. M., Akpan, N., & Jean, Y. Y. (2011). Regulation of caspases in the nervous system implications for functions in health and disease. Progress in Molecular Biology and Translational Science, 99, 265ā305.
Tymianski, M. (2010). Can molecular and cellular neuroprotection be translated into therapies for patients?: Yes, but not the way we tried it before. Stroke, 41, S87āS90.
Van Houten, B., Woshner, V., & Santos, J. H. (2006). Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair, 5, 145ā152.
Vandenabeele, P., Orrenius, S., & Zhivotovsky, B. (2005). Serine proteases and calpains fulfill important supporting roles in the apoptotic tragedy of the cellular opera. Cell Death and Differentiation, 12, 1219ā1224.
Vandongen, A. M. (2009). Biology of the NMDA receptor. Boca Raton, FL: CRC Press.
Volterra, A., Trotti, D., Cassutti, P., Tromba, C., Salvaggio, A., Melcangi, R. C., & Racagni, G. (1992). High sensitivity of glutamate uptake to extracellular free arachidonic acid levels in rat cortical synaptosomes and astrocytes. Journal of Neurochemistry, 59, 600ā606.
Vosler, P. S., Brennan, C. S., & Chen, J. (2008). Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Molecular Neurobiology, 38, 78ā100.
Wang, K. K., Nath, R., Posner, A., Raser, K. J., Buroker-Kilgore, M., Hajimohammadreza, I., Probert, A. W., Jr., Marcoux, F. W., Ye, Q., Takano, E., Hatanaka, M., Maki, M., Caner, H., Collins, J. L., Fergus, A., Lee, K. S., Lunney, E. A., Hays, S. J., & Yuen, P. (1996). An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective. Proceedings of the National Academy of Sciences of the United States of America, 93, 6687ā6692.
Wang, H. G., Pathan, N., Ethell, I. M., Krajewski, S., Yamaguchi, Y., Shibasaki, F., Mckeon, F., Bobo, T., Franke, T. F., & Reed, J. C. (1999). Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science, 284, 339ā343.
Ward, M. W., Rego, A. C., Frenguelli, B. G., & Nicholls, D. G. (2000). Mitochondrial membrane potential and glutamate excitotoxicity in cultured cerebellar granule cells. The Journal of Neuroscience, 20, 7208ā7219.
Watkins, J. C. (1962). The synthesis of some acidic amino acids possessing neuropharmacological activity. Journal of Medicinal and Pharmaceutical Chemistry, 91, 1187ā1199.
Watkins, J. C. (2000). l-Glutamate as a central neurotransmitter: Looking back. Biochemical Society Transactions, 28, 297ā309.
Watkins, J. C., & Evans, R. H. (1981). Excitatory amino acid transmitters. Annual Review of Pharmacology and Toxicology, 21, 165ā204.
Watkins, S., & Sontheimer, H. (2012). Unique biology of gliomas: Challenges and opportunities. Trends in Neurosciences, 35, 546ā556.
Weil-Malherbe, H. (1950). Significance of glutamic acid for the metabolism of nervous tissue. Physiological Reviews, 30, 549ā568.
Wu, H. Y., Tomizawa, K., & Matsui, H. (2007). Calpain-calcineurin signaling in the pathogenesis of calcium-dependent disorder. Acta Medica Okayama, 61, 123ā137.
Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T. I., Jones, D. P., & Wang, X. (1997). Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science, 275, 1129ā1132.
Ye, Z. C., & Sontheimer, H. (1999). Glioma cells release excitotoxic concentrations of glutamate. Cancer Research, 59, 4383ā4391.
Yi, J. H., & Hazell, A. S. (2006). Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury. Neurochemistry International, 48, 394ā403.
Yu, S. W., Wang, H., Poitras, M. F., Coombs, C., Bowers, W. J., Federoff, H. J., Poirier, G. G., Dawson, T. M., & Dawson, V. L. (2002). Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science, 297, 259ā263.
Zoratti, M., & Szabo, I. (1995). The mitochondrial permeability transition. Biochimica et Biophysica Acta, 1241, 139ā176.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2014 Springer Science+Business Media New York
About this entry
Cite this entry
PiƱa-Crespo, J.C., Sanz-Blasco, S., Lipton, S.A. (2014). Concept of Excitotoxicity via Glutamate Receptors. In: Kostrzewa, R. (eds) Handbook of Neurotoxicity. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5836-4_125
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5836-4_125
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5835-7
Online ISBN: 978-1-4614-5836-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences